Patent Grant
D952157
| Number | Name | Date | Kind |
|---|---|---|---|
| D267037 | Spranger | Nov 1982 | S |
| 4496458 | Lee | Jan 1985 | A |
| 4500309 | Diederich et al. | Feb 1985 | A |
| 6143510 | Hoshino et al. | Nov 2000 | A |
| 6277583 | Krantz et al. | Aug 2001 | B1 |
| 7214544 | Poirier et al. | May 2007 | B2 |
| 7226429 | Tullis | Jun 2007 | B2 |
| D579553 | Crnkovich | Oct 2008 | S |
| D600579 | Wounder | Sep 2009 | S |
| 7635598 | Cook et al. | Dec 2009 | B2 |
| 7754499 | Poirier et al. | Jul 2010 | B2 |
| 8288172 | Ichim et al. | Oct 2012 | B2 |
| 8317737 | Hyde et al. | Nov 2012 | B2 |
| 8709428 | Shone et al. | Apr 2014 | B2 |
| 9364601 | Ichim et al. | Jun 2016 | B2 |
| 9452219 | Bates et al. | Sep 2016 | B2 |
| 9707333 | Ichim et al. | Jul 2017 | B2 |
| 10022483 | Tullis | Jul 2018 | B2 |
| 10117933 | Berry et al. | Nov 2018 | B2 |
| 10160797 | Anderson et al. | Dec 2018 | B2 |
| D864397 | Dong | Oct 2019 | S |
| 10744258 | Poirier | Aug 2020 | B1 |
| 20090114595 | Wallenas et al. | May 2009 | A1 |
| 20140263018 | Fuhriman | Sep 2014 | A1 |
| 20160074565 | Giordano | Mar 2016 | A1 |
| 20170095603 | Cho | Apr 2017 | A1 |
| 20190117869 | Handelman et al. | Apr 2019 | A1 |
| 20200397985 | Poirier | Dec 2020 | A1 |
| Number | Date | Country |
|---|---|---|
| 2004064608 | Aug 2004 | WO |
| 2007103572 | Sep 2007 | WO |
| 2010030789 | Mar 2010 | WO |
| 2011005742 | Jan 2011 | WO |
| 2011112873 | Sep 2011 | WO |
| 2015095553 | Jun 2015 | WO |
| 2020176683 | Sep 2020 | WO |
| Entry |
|---|
| Hemoflow Low Volume Dialyzers. Presenius Medical Care. Unknown posting date. Retreived from website on Sep. 17, 2021 at: https://fmcna.com/products/disposables/dialyzers/low-volume-dialyzers/. |
| Ghirelli, C. et al., “Targeting immunosuppression for cancer therapy”, The Journal of Clinical Investigation, vol. 123, No. 6, pp. 2355-2357, (2013). |
| Focosi, D. et al., “Immunosuppressive monoclonal antibodies: current and next generation”, Clinical Microbiology and Infection, vol. 17, pp. 1759-1768, (2011). |
| Chan, A.C. et al., “Therapeutic antibodies for autoimmunity and inflammation”, Nature Reviews Immunology, vol. 10, pp. 301-316, (2010). |
| Zhang, X-B., et al., “Metal ion sensors based on DNAzymes and related DNA molecules”, Annual Review of Analytical Chemistry, vol. 4, No. 1, pp. 105-128, (2011). |
| Hotchkiss, R.S., et al., “Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach”, The Lancet Infectious Diseases, vol. 13, No. 3, pp. 260-268, (2013). |
| “Monoclonal antibodies to treat cancer”, American Cancer Society, found at www.cancer.org/treatment/treatments-and-side-effects/treatment-types/immunotherapy/monoclonal-antibodies.html, pp. 1-5, Printed on Mar. 21, 2019. |
| Zhou, Q. et al., “Aptamer-containing surfaces for selective capture of CD4 expressing cells”, Langmuir, vol. 28, No. 34, p. 12544-12549, (2012). |
| Definition of “Monoclonal antibody therapy” printed from Wikipedia, the free encyclopedia, found at en.wikipedia.org/wiki/Monoclonal_antibody_therapy, Downloaded on Feb. 2, 2017. |
| Mandavilli, A. “Coronavirus can set off a “cytokine storm”. These drugs may calm it”, New York Times, found at www.nytimes.com/2020/06/11/health/coronavirus-cytokine-storm.html?searchResultPosition=1, pp. 1-5, printed on Jun. 16, 2020. |
| Product Description of “Optiflux Dialyzers”, Fresenius Renal Technologies, 2 pages, (2016). |
| Product Description of “Revaclear Dialyzer Technology”, Baxter, 4 pages, (2017). |
| Definition of “Hemodialysis” printed from Wikipedia, the free encyclopedia on Apr. 29, 2020 found at http://en.wikipedia.ora/wiki/Hemodialysis. |
| Definition of “Affinity Chromatography” printed from Wikipedia, the free encyclopedia on May 17, 2018, found at https://en.wikipedia.org/wiki/Affinity_chromatography. |
| Fischer, K-G., “Essentials of anticoagulation in hemodialysis”, Hemodialysis International, vol. 11, issue 2, pp. 178-189 (2007). |
| Frenzel, A. et al., “Expression of recombinant antibodies”, Frontiers in Immunology, vol. 4, article 217, pp. 1-20, (2013). |
| Darvin, P. et al., “Immune checkpoint inhibitors: recent progress and potential biomarkers”, Experimental & Molecular Medicine, vol. 50, article No. 165. pp. 1-11, (2018). |
| González-Rodríguez, E. et al., “Immune checkpoint inhibitors: review and management of endocrine adverse effects”, The Oncologist, vol. 21, pp. 804-816, (2016). |
| Lakhin, A.V. et al. “Aptamers: Problems, Solutions and Prospects”, Acta Naturae, vol. 5, No. 4, pp. 34-43, (2013). |
| Owens, S.M. et al., “Monoclonal antibodies as pharmacokinetic antagonists for the treatment of (+)-methamphetamine addiction”, CNS & Neurological Disorders—Drug Targets, vol. 10, No. 8, pp. 892-898, (2011). |
| “Covalent Immobilization of Affinity Ligands”, ThermoFisher Scientific, found at www.thermofisher.com/us/en/home/life-science/protein-biology/protein-biology-learning-center/protein-biology-resource-library/pierce-protein-methods/covalent-immobilization-affinity-ligands.html, printed on Mar. 17, 2021. |
| Suurmond, J. et al., “Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity”, Journal of Clinical Investigation, vol. 125, No. 6, pp. 2194-2202, (2015). |
| Definition of “List of autoimmune diseases” printed from Wikipedia, the free encyclopedia on Mar. 17, 2021 found at https://en.wikipedia.org/wiki/List_of_autoimmune_diseases. |
| Liu, J. et al. “Rational design of “Turn-On” allosteric DNAzyme catalytic beacons for aqueous mercury ions with ultrahigh sensitivity and selectivity”, Angewandte Chemie International Edition, vol. 119, pp. 7731-7734, (2007). |
| Li, J. et al., “A highly sensitive and selective catalytic DNA biosensor for lead ions”, Journal of the American Chemical Society, vol. 122, No. 42, p. 10466-10467, (2000). |
| Qu, H. et al., “Rapid and label-free strategy to isolate aptamers for metal ions”, ACS Nano, vol. 10, No. 8, pp. 7558-7565, (2016). |
| Banks, M.L. et al., “Immunopharmacotherapies for treating opioid use disorder” Trends in Pharmacological Sciences, vol. 39, issue 11, pp. 908-911, (2018). |
| Rowley et al. “The role of pathogenic autoantibodies in autoimmunity” Antibodies, vol. 4, pp. 314-353, (2015). |
| Tullis, R.H. et al., “Affinity hemodialysis for antiviral therapy. I. removal of HIV-1 from cell culture supernatants, plasma, and blood”, Therapeutic Apheresis and Dialysis, vol. 6, No. 3, pp. 213-220, (2002). |
| Tullis, R.H. et al., “Affinity hemodialysis for antiviral therapy. II Removal of hiv-1 viral proteins from cell culture supernatants and whole blood”, Blood Purification, vol. 21, No. 1, pp. 58-63, (2003). |
| Marleau, A.M. et al., “Exosome removal as a therapeutic adjuvant in cancer”, Journal of Translational Medicine, Biomed Central, vol. 10, No. 1, pp. 1-12,(2012). |